Literature DB >> 12228230

Structural determinants for the biological activity of Vav proteins.

José L Zugaza1, Miguel A López-Lago, María J Caloca, Mercedes Dosil, Nieves Movilla, Xosé R Bustelo.   

Abstract

We have used an extensive mutagenesis approach to study the specific role of the eight structural domains of Vav during both the activation and signaling steps of this Rac1 exchange factor. Our results indicate that several Vav domains (Dbl homology, pleckstrin homology, and zinc finger) are essential for all the biological activities tested, whereas others are required for discrete, cell type-specific biological effects. Interestingly, we have found that Vav domains have no unique functions. Thus, the calponin homology domain mediates the inhibition of Vav both in vitro and in vivo but, at the same time, exerts effector functions in lymphocytes upon receptor activation. The Vav SH2 and SH3 regions play regulatory roles in the activation of Vav in fibroblasts, mediating both its phosphorylation and translocation to the plasma membrane. In contrast, the Vav SH2 and SH3 regions act as scaffolding platforms in T-cells, ensuring the proper phosphorylation of Vav and the subsequent engagement of downstream effectors. We also provide evidence indicating that the zinc finger region exerts at least three different functional roles in Vav, aiding in the down-regulation of its basal activity, the engagement of substrates, and the induction of ancillary pathways required for cell transformation. Finally, the results obtained are consistent with a new regulatory model for Vav, in which the calponin homology region inhibits the basal activity of Vav through interactions with the zinc finger region.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228230     DOI: 10.1074/jbc.M208039200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.

Authors:  Galit Lazer; Liron Pe'er; Marganit Farago; Kazuya Machida; Bruce J Mayer; Shulamit Katzav
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Vav mediates Ras stimulation by direct activation of the GDP/GTP exchange factor Ras GRP1.

Authors:  María J Caloca; José L Zugaza; David Matallanas; Piero Crespo; Xosé R Bustelo
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

3.  Vav1 oncogenic mutation inhibits T cell receptor-induced calcium mobilization through inhibition of phospholipase Cγ1 activation.

Authors:  Mira Knyazhitsky; Etay Moas; Ekaterina Shaginov; Anna Luria; Alex Braiman
Journal:  J Biol Chem       Date:  2012-04-03       Impact factor: 5.157

4.  Rho guanosine nucleotide exchange factors are not such bad guys after all in cancera.

Authors:  Javier Robles-Valero; L Francisco Lorenzo-Martín; Isabel Fernández-Pisonero; Xosé R Bustelo
Journal:  Small GTPases       Date:  2018-01-24

5.  Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion.

Authors:  Rubén A Bartolomé; Isabel Molina-Ortiz; Rafael Samaniego; Paloma Sánchez-Mateos; Xosé R Bustelo; Joaquin Teixidó
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

6.  Global conformational rearrangements during the activation of the GDP/GTP exchange factor Vav3.

Authors:  Oscar Llorca; Ernesto Arias-Palomo; José L Zugaza; Xosé R Bustelo
Journal:  EMBO J       Date:  2005-03-10       Impact factor: 11.598

7.  Vav1 and Rac control chemokine-promoted T lymphocyte adhesion mediated by the integrin alpha4beta1.

Authors:  David García-Bernal; Natalia Wright; Elena Sotillo-Mallo; César Nombela-Arrieta; Jens V Stein; Xosé R Bustelo; Joaquin Teixidó
Journal:  Mol Biol Cell       Date:  2005-05-04       Impact factor: 4.138

8.  Mechanistic analysis of the amplification and diversification events induced by Vav proteins in B-lymphocytes.

Authors:  María J Caloca; José L Zugaza; Xosé R Bustelo
Journal:  J Biol Chem       Date:  2008-10-29       Impact factor: 5.157

9.  Remedial strategies in structural proteomics: expression, purification, and crystallization of the Vav1/Rac1 complex.

Authors:  Alexei Brooun; Scott A Foster; Jill E Chrencik; Ellen Y T Chien; Anand R Kolatkar; Markus Streiff; Paul Ramage; Hans Widmer; Gisbert Weckbecker; Peter Kuhn
Journal:  Protein Expr Purif       Date:  2006-12-05       Impact factor: 1.650

10.  TCR-driven transendothelial migration of human effector memory CD4 T cells involves Vav, Rac, and myosin IIA.

Authors:  Thomas D Manes; Jordan S Pober
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.